According to Revolution Medicines
's latest financial reports the company has NZ$3.52 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | NZ$4.05 B | 38.54% |
2023-12-31 | NZ$2.93 B | 188.44% |
2022-12-31 | NZ$1.01 B | 20.24% |
2021-12-31 | NZ$0.84 B | 38.31% |
2020-12-31 | NZ$0.61 B | 235.12% |
2019-12-31 | NZ$0.18 B | 75.7% |
2018-12-31 | NZ$0.10 B | 711.5% |
2017-12-31 | NZ$12.78 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | NZ$0.34 B | -90.31% | ๐บ๐ธ USA |